Adenoviruses Using the Cancer Marker EphA2 as a Receptor In Vitro and In Vivo by Genetic Ligand Insertion into Different Capsid Scaffolds-Reference-Cited by-同舟云学术

Adenoviruses Using the Cancer Marker EphA2 as a Receptor In Vitro and In Vivo by Genetic Ligand Insertion into Different Capsid Scaffolds

Published:2014-04-23 Issue:4 Volume:9 Page:e95723
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Behr Michael,Kaufmann Johanna K.,Ketzer Patrick,Engelhardt Sarah,Mück-Häusl Martin,Okun Pamela M.,Petersen Gabriele,Neipel Frank,Hassel Jessica C.,Ehrhardt Anja,Enk Alexander H.,Nettelbeck Dirk M.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference64 articles.

1. New insights on adenovirus as vaccine vectors;MO Lasaro;Mol Ther,2009

2. Current issues and future directions of oncolytic adenoviruses;M Yamamoto;Mol Ther,2010

3. Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis;DE Dorer;Adv Drug Deliv Rev,2009

4. MicroRNA-regulated transgene expression systems for gene therapy and virotherapy;F Sakurai;Front Biosci,2011

5. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5;JM Bergelson;Science,1997

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Erythropoietin-induced hepatocyte receptor A2 regulates effect of pyroptosis on gastrointestinal colorectal cancer occurrence and metastasis resistance;World Journal of Gastrointestinal Oncology;2024-09-15

2. Patient-derived melanoma models;Pathology - Research and Practice;2024-07

3. Advancements in melanoma cancer metastasis models;Pigment Cell & Melanoma Research;2023-02-07

4. Genetic and Chemical Capsid Modifications of Adenovirus Vectors to Modulate Vector–Host Interactions;Viruses;2021-07-02

5. Strategies to Develop Potent Oncolytic Viruses and Enhance Their Therapeutic Efficacy;JCO Precision Oncology;2021-04